Seminars in Nuclear Medicine
Volume 36, Issue 3 , Pages 212-227 , July 2006

Adrenal Gland Scintigraphy

  • Anca M. Avram, MD

      Affiliations

    • Department of Radiology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI.
    • Corresponding Author InformationAddress reprint requests to Anca M. Avram, MD, Division of Nuclear Medicine, Department of Radiology, B1G 505G University Hospital, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109-0028.
    • ,
  • Lorraine M. Fig, MBChB, MPH

      Affiliations

    • Department of Radiology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI.
    • Department of Veterans Affairs Health Systems, Ann Arbor, MI.
    • ,
  • Milton D. Gross, MD

      Affiliations

    • Department of Radiology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI.
    • Department of Veterans Affairs Health Systems, Ann Arbor, MI.

References 

  1. Gross MD , Shapiro B , Bui C , et al.   Adrenal scintigraphy and metaiodobenzylguanidine therapy of neuroendocrine tumors . In:  Sandler RE ,  Coleman JA ,  Patton FJ , et al. editor. Diagnostic Nuclear Medicine . (ed 4). Philadelphia: Lippincott Williams and Wilkins; 2003;p. 715–734
  2. Gross MD , Bui C , Shapiro B . Adrenocortical scintigraphy . In:  Ell PJ ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment . (ed 3). Edinburgh, Churchill and Livingstone; 2004;p. 45–52
  3. Gross MD , Korobkin M , Hussain H , et al.   Adrenal gland imaging . In:  Jameson JL ,  DeGroot LJ editor. Endocrinology . (ed 5). Philadelphia: W. B. Saunders; 2005;p. 2425–2453
  4. Gross MD , Rubello D , Shapiro B . Is there a future for adrenal scintigraphy? . Nucl Med Commun . 2002;23:197–202
  5. Gross MD , Valk TW , Thrall JH , et al.   The role of pharmacologic manipulation in adrenal cortical scintigraphy . Semin Nucl Med . 1981;11:128–148
  6. Gross MD , Shapiro B . Scintigraphic studies in adrenal hypertension . Semin Nucl Med . 1990;19:122–143
  7. Shapiro B , Gross MD , Shulkin BL . Radioisotope diagnosis and therapy of malignant pheochromocytomas . Trends Endocrinol Metab . 2001;12:469–475
  8. Rubello D , Bui C , Casara D , et al.   Functional scintigraphy of the adrenal gland . Eur J Endocrinol . 2002;147:13–28
  9. Gross MD , Shapiro B , Shreve P . Radionuclide imaging of the adrenal cortex . Q J Nucl Med . 1999;43:224–232
  10. Sisson JC , Frager MS , Valk TW , et al.   Scintigraphic localization of pheochromocytoma . N Engl J Med . 1981;305:12
  11. Shapiro B , Wieland DM , Brown LE , et al.   131I-meta-iodobenzylguaindine (MIBG) adrenal medullary scintigraphy (interventional studies) . In:  Spencer RP editors. Interventional Nuclear Medicine . New York: Grune & Stratton; 1983;p. 451–481
  12. Khafagi FA , Shapiro B , Fig LM , et al.   Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues . J Nucl Med . 1989;30:481–489
  13. Ilias I , Shulkin B , Pacak K . New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas . Trends Endocrinol Metab . 2005;16:66–72
  14. Ilias I , Yu J , Carrasquillo JA , et al.   Superiority of 6-18F-fluorodopamine positron emission tomography versus 131-I metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma . J Clin Endocrinol Metab . 2003;88:4083–4087
  15. Mamede M , Carrasquillo JA , Chen CC , et al.   Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites . Nucl Med Commun . 2006;27:31–36
  16. Van der Harst E , de Herder WW , Bruining HA , et al.   123I-Metaiodobenzylguanidine and 111In-octreotide uptake in benign and malignant pheochromocytomas . J Clin Endocrinol Metab . 2001;86:685–693
  17. Yun M , Kim W , Alnafisi N , et al.   18F-FDG PET in characterizing adrenal lesions detected on CT or MRI . J Nucl Med . 2001;42:1795–1799
  18. Sohaib SA , Hanson JA , Reznek RH , et al.   CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing Syndrome . AJR Am J Roentgenol . 1999;172:997–1002
  19. Schteingart DE , Seabold JE , Gross MD , et al.   Iodocholesterol adrenal tissue uptake and imaging in adrenal neoplasms . J Clin Endocrinol Metab . 1981;52:1156
  20. Fig LM , Ehrmann D , Gross MD , et al.   The localization of abnormal adrenal function in the ACTH-independent Cushing syndrome . Ann Intern Med . 1988;109:547–553
  21. Gross MD , Freitas JE , Swanson DP , et al.   Dexamethasone suppression adrenal scintigraphy in hyperandrogenism . J Nucl Med . 1981;22:12
  22. Nakajo M , Sakata H , Shinohara S . Positive imaging of arrhenoblastoma of the ovary with 131-I-aldosterol (case report) . Jpn J Nucl Med . 1979;16:472
  23. Barkan AL , Cassorla F , Loriaux DL , et al.   Steroid and gonadotrophin secretion in a patient with a 30-year history of virilization due to a lipoid-cell ovarian tumor . Obstet Gynecol . 1984;64:287
  24. Carpenter DC , Wahner HW , Salassa RM , et al.   Demonstration of steroid producing gonadal tumors by external scanning with the use of NP-59 . Mayo Clin Proc . 1979;54:332
  25. Pacak K , Eisenhofer G , Goldstein DS . Functional imaging of endocrine tumors (role of positron emission tomography) . Endocr Rev . 2004;25:568–580
  26. Minn H , Salonen A , Friberg J , et al.   Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG . J Nucl Med . 2004;45:972–979
  27. Zettinig G , Mitterhauser M , Wadsak W , et al.   Positron emission tomography imaging of adrenal masses ((18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate) . Eur J Nucl Med Mol Imaging . 2004;31:1224–1230
  28. Kloos RT , Gross MD , Francis IR , et al.   Incidentally discovered adrenal masses . Endocr Rev . 1995;16:460–484
  29. Boland GW , Lee MJ , Gazelle GS , et al.   Characterization of adrenal masses using unenhanced CT (an analysis of the CT literature) . AJR Am J Roentgenol . 1998;171:201–204
  30. Korobkin M , Brodeur FJ , Francis IR , et al.   CT time-attenuation washout curves of adrenal adenomas and nonadenomas . AJR Am J Roentgenol . 1998;170:747–752
  31. Outwater EK , Siegelman ES , Radecki PD , et al.   Distinction between benign and malignant adrenal masses (value of T1-weighted chemical-shift MR imaging) . AJR Am J Roentgenol . 1995;165:579–583
  32. Maurea S , Klain M , Mainolfi C , et al.   The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses . J Nucl Med . 2001;42:884–892
  33. Maurea S , Caraco C , Klain M , et al.   Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques . Q J Nucl Med Mol Imaging . 2004;48:188–197
  34. Erasmus JJ , Patz EF , McAdams HP , et al.   Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-FDG PET . AJR Am J Roentgenol . 1997;168:1357–1360
  35. Rao SK , Caride VJ , Ponn R , et al.   F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma (imaging features and pathologic correlation) . Clin Nucl Med . 2004;29:300–302
  36. Shimizu A , Oriuchi N , Tsushima Y , et al.   High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing’s syndrome . Ann Nucl Med . 2003;17:403–406
  37. Ludwig V , Rice MH , Martin WH , et al.   2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma . Mol Imaging Biol . 2002;4:355–358
  38. Mukherjee JJ , Peppercorn PD , Reznek RH , et al.   Pheochromocytoma (Effect of nonionic contrast medium in CT on circulating catecholamine levels) . Radiology . 1997;202:227–231
  39. Francis IR , Korobkin M . Pheochromocytoma . Radiol Clin N Am . 1996;34:1101–1112
  40. Shapiro B , Sisson JC , Kalff V , et al.   The location of middle mediastinal pheochromocytomas . J Thorac Cardiovasc Surg . 1984;87:814
  41. Shulkin BL , Thompson NW , Shapiro B , et al.   Pheochromocytomas (imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET) . Radiology . 1999;212:35–41
  42. Ilias I , Pacak K . Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma . J Clin Endocrinol Metab . 2004;89:479–491

PII: S0001-2998(06)00017-1

doi: 10.1053/j.semnuclmed.2006.03.004

Seminars in Nuclear Medicine
Volume 36, Issue 3 , Pages 212-227 , July 2006

Article Tools

* Image Usage & Resolution